Literature DB >> 30144232

Intranasal dexmedetomidine, as midazolam-sparing drug, for MRI in preterm neonates.

Jenny Bua1, Marta Massaro2, Francesca Cossovel2, Lorenzo Monasta1, Pierpaolo Brovedani1, Giorgio Cozzi1, Egidio Barbi1,2, Sergio Demarini1, Laura Travan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30144232     DOI： 10.1111/pan.13454

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN： 1155-5645            Impact factor:   2.556


× No keyword cloud information.
  5 in total

Review 1.  Sedation and analgesia from prolonged pain and stress during mechanical ventilation in preterm infants: is dexmedetomidine an alternative to current practice?

Authors:  Shalini Ojha; Janine Abramson; Jon Dorling
Journal:  BMJ Paediatr Open       Date:  2022-05

2.  Safety and effectiveness of intranasal dexmedetomidine together with midazolam for sedation in neonatal MRI.

Authors:  Emanuela Inserra; Umberto Colella; Elisabetta Caredda; Mario Diplomatico; Simona Puzone; Sabino Moschella; Carlo Capristo; Gioacchino Tedeschi; Ferdinando Caranci; Mario Cirillo; Emanuele Miraglia Del Giudice; Paolo Montaldo
Journal:  Paediatr Anaesth       Date:  2021-10-12       Impact factor: 2.129

3.  Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam.

Authors:  Francesca Cossovel; Andrea Trombetta; Augusto Ramondo; Guglielmo Riccio; Luca Ronfani; Alessia Saccari; Giorgio Cozzi; Egidio Barbi
Journal:  Ital J Pediatr       Date:  2022-01-10       Impact factor: 2.638

4.  Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary.

Authors:  Jolien J M Freriksen; Tjitske M van der Zanden; Inge G A Holsappel; Bouwe Molenbuur; Saskia N de Wildt
Journal:  Paediatr Drugs       Date:  2022-03-28       Impact factor: 3.930

5.  Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children.

Authors:  Hang Chen; Fei Yang; Mao Ye; Hui Liu; Jing Zhang; Qin Tian; Ruiqi Liu; Qing Yu; Shangyingying Li; Shengfen Tu
Journal:  BMC Anesthesiol       Date:  2020-03-07       Impact factor: 2.217
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.